ResveraCel
Best-in-class: ResveraCel
Thorne ResveraCel. Per two capsules the filed panel declares nicotinamide riboside hydrogen malate 415 mg, quercetin phytosome 250 mg from Sophora japonica flower extract, trans-resveratrol 150 mg and betaine anhydrous (trimethylglycine) 85 mg. There is no pterostilbene in it — copy on this page used to name one, and the filed label does not.
ResveraCel quick facts
| Suggested dose | Two capsules daily. |
| How often | Daily |
| Who it's for | Longevity, NAD+ and metabolic-aging experimenters wanting the combined pathway. |
| Best-in-class brand | ResveraCel |
The most coherent of the longevity stacks, though each ingredient carries its own uncertainty and combining them doesn't resolve any of it. Resveratrol in particular has had a rough decade — bioavailability is poor and the human trials have largely disappointed relative to the early excitement. The methyl-donor inclusion is the part that shows someone thought about the downstream consequence rather than just stacking buzzwords. Reasonable if you want the category in one capsule; not a substitute for the basics.
How ResveraCel actually works
A combination formula, and the components target different points of the same axis rather than duplicating each other. Nicotinamide riboside supplies NAD+ substrate. Resveratrol is included as a proposed sirtuin activator — the enzymes that consume that NAD+ — on the logic that substrate without activation does less. Quercetin is there partly as a senolytic candidate and partly because it slows resveratrol's metabolism. Betaine is the outlier and arguably the most defensible: it's a methyl donor, and clearing excess nicotinamide consumes methyl groups, so it addresses a real cost of the rest.
Where to get ResveraCel
Buy ResveraCel at Thorne →The evidence for ResveraCel
Graded by what exists behind each claim.
✅ Clinically validated
- NR reliably raises NAD+ (well-established); resveratrol and NAD+ activate sirtuin pathways.
- Includes TMG to support methylation, which NAD+ boosters can deplete.
📊 Correlative data
- NAD+ and sirtuin activity decline with age, tracking with metabolic and mitochondrial aging.
🧪 Theoretical / extrapolated benefits
- A thoughtfully-designed 'longevity stack' — the mechanism is strong, but human healthspan outcomes remain unproven.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What ResveraCel actually does
Start with what is actually in the bottle, because this card once said something else. The filed Supplement Facts panel for Thorne ResveraCel declares, per 2-capsule serving, nicotinamide riboside hydrogen malate 415 mg, quercetin phytosome 250 mg, trans-resveratrol 150 mg and betaine anhydrous 85 mg Office of Dietary Supplements. There is no pterostilbene on it. The second-largest ingredient in the formula is a quercetin phytosome, and the card claimed a different polyphenol in that slot until it was checked against the panel.
The formula is a NAD argument, and NAD is a buffered pool rather than a tank. Nicotinamide riboside enters through nicotinamide riboside kinase to nicotinamide mononucleotide and then to NAD. That route is real and it raises measured NAD in blood in supplemented adults Martens 2018. What it does not do is raise a level that was falling: whole-blood NAD in humans does not vary with age or with lifestyle interventions Tretowicz 2026, which removes the premise most of this category is sold on.
The betaine is the tell, and it names the controller. Nicotinamide N-methyltransferase disposes of surplus nicotinamide by methylating it with S-adenosylmethionine, and it sits at the intersection of NAD metabolism and the methyl economy Roberti 2021. Put 415 mg of a nicotinamide riboside salt into a person and you have increased the flux through a methyltransferase; betaine anhydrous is on the panel to feed the methyl pool that methyltransferase draws on. The formula is designed around a controller, which is more than most formulas do.
And the fourth ingredient is aimed at the consumer of NAD rather than its supply. CD38 is the dominant NAD-consuming ectoenzyme in aging tissue and it is inhibited by flavonoids, apigenin among them Escande 2013. Quercetin is in the same structural family, so the quercetin phytosome has a coherent reason to be there even though it is usually sold as a senolytic. Four ingredients, three of them pointed at one pathway from three different sides.
Cell, rodent, human — and where it stops
This is a rare formula where the individual translation chains are documented and the joint one is not.
Nicotinamide riboside has real human data. Chronic supplementation is well tolerated and elevates NAD in middle-aged and older adults Martens 2018, and a dedicated randomized double-blind safety trial has taken it to high dose in Parkinson's disease Berven 2023. Very few supplement ingredients on this site have a trial whose primary purpose was safety at the top of the range.
The methyl-depletion worry has been tested, and it failed. The argument for adding betaine is that heavy nicotinamide methylation drains S-adenosylmethionine Roberti 2021. A clinical study looked for exactly that and found nicotinamide riboside supplementation was not associated with altered methylation homeostasis Gaare 2023. That is a negative result for the rationale of one of the four ingredients, and it is the most interesting single fact on this page.
Resveratrol is where the chain snaps. Phase I dose escalation in healthy volunteers found resveratrol absorbed and then conjugated so fast that parent-compound plasma concentrations sat far below the levels the cell literature works at, with sulfate and glucuronide metabolites dominating Boocock 2007. 150 mg is at the low end even of the doses that study escalated through.
The specific obstacle for the product as sold is that no trial has ever tested it. Four ingredients at four doses is a combination, and the combination has no trial of its own. The panel amounts also sit below several of the single-ingredient trial doses Office of Dietary Supplements, so even the component evidence is being quoted at a strength the capsule does not deliver.
ResveraCel — which form, and does it matter
The salt on the panel is not the salt in the trials, and here that is a real difference. The published human work used nicotinamide riboside chloride Martens 2018 Berven 2023. This panel declares nicotinamide riboside hydrogen malate Office of Dietary Supplements. Malate is heavier than chloride, so 415 mg of the malate salt is not 415 mg of the chloride salt in delivered nicotinamide riboside, and nothing on the label converts one to the other.
The quercetin is a phytosome and that is the whole reason it can be dosed at 250 mg. Plain quercetin is poorly absorbed; a phospholipid complex raises the absorbed fraction substantially. A reader comparing this to a 500 mg plain quercetin capsule is comparing label weights across two different bioavailability classes.
The resveratrol is declared as trans-resveratrol, which is the right specification and an incomplete one. The trans isomer is the active one and it photoisomerizes to cis on exposure to light. A resveratrol product's real form question is packaging and storage, and no panel reports isomeric purity at the end of shelf life Boocock 2007.
One filing note a buyer should have. DSLD record 323129 is the most recent filing and is marked off market as of 28 March 2025, as is every earlier ResveraCel filing, while the product is still listed for sale Office of Dietary Supplements. The panel above is the last one filed rather than a guaranteed current one, and it should be re-read against the physical bottle.
What would have to be true, and how you would know it was not
1. The NAD prediction, at 8 weeks, and it should succeed. Whole-blood NAD before and after. Predict a rise, because that is the single most reproducible finding in this literature Martens 2018. Predict also that the rise tells you nothing about how old your cells are, because the baseline does not track age Tretowicz 2026.
2. The methylation prediction, and it cuts against the formula. Homocysteine at baseline and 12 weeks. If the methyl-drain rationale for the betaine were right, nicotinamide riboside alone would raise homocysteine and betaine would prevent it. Predict no meaningful movement in either direction, because methylation homeostasis was measured and did not shift Gaare 2023.
3. The inflammation prediction, at 12 weeks. High-sensitivity C-reactive protein. Predict no change. The CD38 argument Escande 2013 is a tissue-level mechanism with no demonstrated human systemic inflammatory read-out at these doses, and saying so is more useful than promising one.
4. The liver prediction, because four actives is four actives. Alanine aminotransferase and aspartate aminotransferase at baseline and 16 weeks. Predict no change. This is a monitoring prediction rather than an efficacy one, and it exists because the safety profile of a combination is the sum of its parts rather than their average.
5. The experiment nobody has run on this product. Four arms: the full formula, nicotinamide riboside alone, the formula without betaine, and placebo. Whole-blood NAD and homocysteine at 12 weeks. If the formula beats nicotinamide riboside alone on NAD, the combination has earned its price. If it does not, this is a nicotinamide riboside product with three passengers Office of Dietary Supplements.
What nobody has tested yet
Nobody has tested this combination against its own largest ingredient. Every claim available for this product is borrowed from a single-ingredient trial, and the borrowing is at doses the panel does not always match Office of Dietary Supplements.
Nobody has published pharmacokinetics for the malate salt. The human trials used the chloride Martens 2018. Whether the hydrogen malate delivers equivalent nicotinamide riboside per milligram has not been shown in a person.
Nobody knows what raising NAD does to a person whose NAD was never low. The intervention reliably raises the measurement Martens 2018 and the measurement does not fall with age Tretowicz 2026. The clinical meaning of moving a variable that was not drifting is the open question under this entire category.
And nobody has measured nicotinamide N-methyltransferase activity in supplemented humans. The enzyme is the named controller Roberti 2021 and the one clinical look at the downstream methyl economy found it undisturbed Gaare 2023. Measuring the enzyme itself, rather than its supposed consequence, has not been done.
ResveraCel — its own safety story, not its category's
This is one product with four actives, and the risks add rather than average. The most common way to overdose a single ingredient is to meet it twice in one day under two product names, and a NAD formula sits beside standalone nicotinamide riboside, standalone quercetin and standalone resveratrol on most shelves Office of Dietary Supplements.
Resveratrol is the ingredient with the interaction that matters. It has antiplatelet activity and inhibits several cytochrome P450 enzymes at achievable gut concentrations, which is a real consideration alongside anticoagulants, antiplatelets and narrow-therapeutic-index drugs. The dose here is modest and the systemic exposure is low Boocock 2007, which lowers the concern without removing it.
Nicotinamide riboside itself has been taken to high dose under trial conditions. A randomized double-blind safety trial in Parkinson's disease is the strongest safety document any ingredient in this bottle has Berven 2023, and it is a study in a patient population rather than a license for indefinite use in a well person.
Quercetin at meaningful absorbed doses is not neutral either. It inhibits several drug-metabolizing and transport proteins, and a phytosome is specifically designed to raise the absorbed fraction. Anyone on a medication with a narrow window should treat this formula as a change worth mentioning to the prescriber.
And the filing status is a safety fact, not a trivia fact. The most recent DSLD record is marked off market while the product is sold Office of Dietary Supplements, so the panel above should be checked against the bottle in hand before anyone reasons about doses from it. Nothing here is medical advice, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Office of Dietary Supplements, National Institutes of Health. ResveraCel (Thorne) -- filed Supplement Facts panel, 2 capsules daily: nicotinamide riboside hydrogen malate 415 mg, quercetin phytosome from Sophora japonica flower extract 250 mg, trans-resveratrol 150 mg, betaine anhydrous (trimethylglycine) 85 mg; no pterostilbene; record marked off market 28 March 2025. NIH Dietary Supplement Label Database, DSLD ID 323129
- Roberti A. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Mol Metab 2021 · PMID 33453420
- Gaare JJ. Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. iScience 2023 · PMID 36936793
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nature Communications, 2018 · PMID 29599478
- Berven H, et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. Nature Communications 2023 · PMID 38016950
- Tretowicz MM. Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nat Metab 2026 · PMID 42135539
- Boocock DJ, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.. Cancer Epidemiology, Biomarkers & Prevention 2007 · PMID 17548692
- Escande C, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.. Diabetes 2013 · PMID 23172919
How you would know if it worked
Three mechanisms in one capsule, and only one of them has a number that is certain to move. The TMG is in this formula because raising NAD+ consumes methyl groups, so homocysteine is the direct test of whether that design decision actually works: on a well-formulated NAD+ stack it should hold steady or fall, and a rise means the methyl donors are not keeping up with the nicotinamide. The pterostilbene half is a lipid question, and an honest one — draw a lipid panel first and read it as an open question rather than an expected win.
- Homocysteine Retest: 8–12 weeks after starting B vitamins.
- Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) Retest: Every 3–6 months on androgens; annually otherwise.
The cheapest panel carrying Homocysteine and at least one other of these is Real Cardiovascular Risk, at $208 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
ResveraCel — safety & side effects
- Combines NR with resveratrol, quercetin and TMG. The resveratrol antiplatelet and CYP interactions apply, and so does the TMG effect on LDL.
- Read the NR, resveratrol, quercetin and betaine pages — the blend does not have a safety profile of its own beyond theirs.
The same on every page it applies to. Read it here; it is not repeated research.
- This is one formula with several actives, and it carries the combined safety profile of everything on its panel — the risks do not average out, they add. Check the panel above against anything else you take, because the commonest way to overdose an ingredient is to meet it twice in one day under two different product names.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Build your foundation with Coach Cam
The full Supplement Vault — 371 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside Skool alongside 278 peptides.
Join Skool — $10/mo →Bloodwork to run alongside ResveraCel
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
ResveraCel — frequently asked questions
What is ResveraCel?
Thorne ResveraCel. Per two capsules the filed panel declares nicotinamide riboside hydrogen malate 415 mg, quercetin phytosome 250 mg from Sophora japonica flower extract, trans-resveratrol 150 mg and betaine anhydrous (trimethylglycine) 85 mg. There is no pterostilbene in it — copy on this page used to name one, and the filed label does not.
What is the suggested dose of ResveraCel?
Two capsules daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
What are the researched benefits of ResveraCel?
NR reliably raises NAD+ (well-established); resveratrol and NAD+ activate sirtuin pathways.
Who is ResveraCel for?
Longevity, NAD+ and metabolic-aging experimenters wanting the combined pathway.
Where can I buy ResveraCel?
Coach Cam sources ResveraCel from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
What ResveraCel is used for
ResveraCel appears under 1 goal in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.